Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
NBF-006
i
Other names:
NBF-006, NBF 006, NBF006
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Nitto Denko
Drug class:
Glutathione S transferase P inhibitor, RNA interference
Related drugs:
‹
ION537 (0)
PH-894 (0)
TTX-siPDL1 (0)
ION537 (0)
PH-894 (0)
TTX-siPDL1 (0)
›
Associations
News
Trials
Phase
Status
Apply
Phase
Status
Apply
A Study of NBF-006 in Non-Small Cell Lung, Pancreatic, or Colorectal Cancer (NCT03819387)
Phase 1
Nitto BioPharma, Inc.
Nitto BioPharma, Inc.
Active, not recruiting
Phase 1
Nitto BioPharma, Inc.
Active, not recruiting
Last update posted :
08/31/2023
Initiation :
03/18/2019
Primary completion :
03/01/2024
Completion :
08/01/2024
KRAS
|
KRAS mutation
|
NBF-006
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login